1,299 results on '"McCullough, Arthur"'
Search Results
202. Factors Associated With Histologic Response in Adult Patients With Nonalcoholic Steatohepatitis.
203. The association of nonalcoholic steatohepatitis and hepatocellular carcinoma.
204. Quantification of carbohydrate oxidation by respiratory gas exchange and isotopic tracers
205. Omeprazole versus placebo in duodenal ulcer healing: The United States experience
206. Surprisingly Small Effect of Antiviral Treatment in Patients with Hepatitis C
207. Nonalcoholic Fatty Liver Disease: A Feature of the Metabolic Syndrome
208. Relationship between leucine oxidation and oxygen consumption during steady-state exercise
209. Clinical Features and Natural History of Nonalcoholic Steatosis Syndromes
210. A randomized, double-blind controlled trial of interferon alpha-2b and ribavirin vs. interferon alpha-2b and amantadine for treatment of chronic hepatitis C non-responder to interferon monotherapy
211. Plasma Proteome Dynamics: Analysis of Lipoproteins and Acute Phase Response Proteins with 2H2O Metabolic Labeling
212. Obesity and its nurturing effect on hepatitis C
213. Trends in pioglitazone use among U.S. adults with type 2 diabetes and suspected nonalcoholic fatty liver disease
214. Hospital readmission following transjugular intrahepatic portosystemic shunt: a 14-year single-center experience
215. HDL flux is higher in patients with nonalcoholic fatty liver disease
216. 1051 Association Between Vitamin D Deficiency and Nonalcoholic Fatty Liver Disease (NAFLD)
217. 973 Utility of Gram Stain in the Diagnosis and Management of Spontaneous Bacterial Peritonitis: Promoting High Value Care
218. 478 Assessing the Relation Between Irritable Bowel Syndrome and Nonalcoholic Liver Disease
219. 2958 Assessing the Association Between Psoriasis and Nonalcoholic Liver Disease
220. 1190 Does Nonalcoholic Fatty Liver Disease Increase the Risk for Acute Ischemic Bowel Disease?
221. 986 The Risk of Depression in Patients With Nonalcoholic Fatty Liver Disease
222. 946 Factors Leading to Discordance Between Vibration-Controlled Transient Elastography and Liver Biopsy in Patients With Non-Alcoholic Fatty Liver Disease
223. 943 A Step-Wise Approach to Non-Invasive Diagnosis of Advanced Fibrotic Disease in NAFLD
224. Impact of sleeve gastrectomy and Roux-en-Y gastric bypass on biopsy-proven non-alcoholic fatty liver disease
225. Awareness of Nonalcoholic Fatty Liver Disease Is Increasing but Remains Very Low in a Representative US Cohort
226. Biomarkers of Macrophage Activation and Immune Danger Signals Predict Clinical Outcomes in Alcoholic Hepatitis
227. Mo1457 – The Risk of Hepatocellular Carcinoma in Cirrhotic Patients with Hbv and Hcv Infection: Not an Equal Opportunity
228. Mo1539 – Assessing the Risk for Acute Ischemic Bowel Disease in Irritable Bowel Syndrome Patients
229. Sa1642 – Trends in Inpatient Admissions and Healthcare Outcomes in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD): Analysis Using National Inpatient Sample Database (NIS) from 1998 to 2013
230. Tu1488 – Hepatitis C-Cirrhosis and Mortality in a National Inpatient Population
231. Sa1773 – Nonalcoholic Liver Disease Significantly More Prevalent in Ulcerative Colitis: A Population-Based Study
232. Sa1618 – Characteristics of Nonalcoholic Fatty Liver Disease in Patients with Severe Obesity: Insights from 3077 Consecutive Liver Biopsies
233. Sa1565 – Higher Uric Acid Levels are Associated with Fibrosis in Nonalcoholic Fatty Liver Disease (NAFLD)
234. Sa1774 – Increased Prevalence of Nonalcoholic Liver Disease in Crohn's Disease: A Population-Based Study
235. Assessing liver fibrosis without biopsy in patients with HCV or NAFLD
236. Steatohepatitis in obese individuals
237. The TMAO-Producing Enzyme Flavin-Containing Monooxygenase 3 Regulates Obesity and the Beiging of White Adipose Tissue
238. A Cost Analysis of Alternative Treatments for Duodenal Ulcer
239. Glutamine - a conditionally essential amino acid in cirrhosis?
240. Diagnostic and Prognostic Significance of Complement in Patients With Alcohol‐Associated Hepatitis.
241. Do Corticosteroids Reduce Mortality from Alcoholic Hepatitis?: A Meta-analysis of the Randomized Trials
242. Renal and Hemodynamic Effects of Atrial Natriuretic Peptide in Patients with Cirrhosis
243. Multicenter Validation of Association Between Decline in MRI‐PDFF and Histologic Response in NASH.
244. Hospital readmission following transjugular intrahepatic portosystemic shunt: a 14-year single-center experience.
245. Effect of Alcohol Consumption on Survival in Nonalcoholic Fatty Liver Disease: A National Prospective Cohort Study
246. The Outcome of Acute Pancreatitis in Patients With Cannabinoid Abuse
247. Clinical Predictors of High Healthcare Utilization Among Patients With Acute Cholangitis: Analysis From the National Readmission Database
248. Assessing the Risk of Osteoporosis in Patients with Inflammatory Bowel Disease
249. Trends and Risk Factors for 30-Day Readmissions in Patients With Acute Cholangitis: Analysis From the National Readmission Database: Presidential Poster Award
250. Recurrent Primary Sclerosing Cholangitis in Transplanted Liver: A Longitudinal Cohort
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.